Creative Biolabs-Immuno-oncology

PharmaOnco™ Human NCI-N87-Luc Tumor Cell Line (CAT#: IOC-02P034)

DatasheetDatasheet
Short Description
Luciferase-labeled human NCI-N87 cell
Description
Researchers at the Creative Biolabs have developed an Luciferase-labeled human NCI-N87 cell that allows for intravital imaging to evaluate anti-cancer agents in Colon cancer. Furthermore, the Luciferase-labeled human NCI-N87 cell is helpful in assessing the tumor- take to select mice for treatments groups based on equivalent tumor burden.
Applications
in vivo Imaging
Organism
Human
Disease
Gastric Carcinoma
Tested Data Related Products

COACOA

IOC-02P034-1 Fig.1 Cell morphology of PharmaOnco™ Human NCI-N87-Luc Tumor Cell Line (CAT#: IOC-02P034).

Cell Morphology

Cell morphology under the bright field.

IOC-02P034-2 Fig.2 LUC expression in PharmaOnco™ Human NCI-N87-Luc Tumor Cell Line (CAT#: IOC-02P034).

LUC Expression Test

The LUC intensity was detected by luciferase.

IOC-02P034-3 Fig.3 Mycoplasma Testing of PharmaOnco™ Human NCI-N87-Luc Tumor Cell Line (CAT#: IOC-02P034).

Mycoplasma Testing

Mycoplasma contamination is detected by using a PCR Mycoplasma Test Kit. The kit utilizes the polymerase chain reaction (PCR), which was established as the method of choice for the highest sensitivity in the detection of mycoplasma and acholeplasma contamination in cell cultures and other cell culture derived biologicals.
The results showed that the cell line was negative for Mycoplasma.
Lane M: Marker;
Lane 1: Cell culture medium from NCI-N87-LUC
Lane 2: Negative control;
Lane 3: Positive control;

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.